Behavioral Intervention

Mindful Self-Compassion for Lung Cancer

Los Angeles, CA

N/A

Recruiting

Led By Timothy J Williamson, Ph.D., MPH

Research Sponsored by Loyola Marymount University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Is at least 18 years of age as per self report

Has a confirmed lung cancer diagnosis, as per self-report and confirmed by clinician judgment or medical record note

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a mindfulness-based program called Mindful Self-Compassion for Lung Cancer (MSC-LC) in adults with lung cancer who experience stigma. The goal is to see if this

Who is the study for?

This trial is for adults with lung cancer who feel stigmatized because of their diagnosis. Participants will be randomly assigned to either learn mindfulness and self-compassion skills in a virtual group setting over 10 weeks or placed on a waitlist while receiving standard mental health resources.

What is being tested?

Researchers are testing a new program called Mindful Self-Compassion for Lung Cancer (MSC-LC) against an enhanced standard of care. They want to see if MSC-LC can help reduce feelings of stigma and increase self-kindness among lung cancer patients.

What are the potential side effects?

Since this intervention involves mindfulness and self-compassion exercises, it's not expected to have physical side effects. However, discussing sensitive topics like stigma may cause temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with lung cancer, confirmed by my doctor.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Lung Cancer Stigma Inventory

Secondary study objectives

Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being, meaning and peace subscales

Generalized Anxiety Disorder-7

Patient Health Questionnaire-8

+1 more

Other study objectives

Number of intervention sessions that each consented participant attended

Treatment fidelity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindful Self-Compassion for Lung Cancer (MSC-LC)Experimental Treatment1 Intervention

Group-based psychosocial intervention adapted from Mindful Self-Compassion that focuses on the development of mindfulness and self-compassion skills to reduce lung cancer stigma.

Group II: Enhanced standard of care with waitlistActive Control1 Intervention

Control group that will receive a list of mental health resources and will complete questionnaire assessments during a parallel timeframe as participants in the intervention condition and be placed on a waiting list to receive the MSC-LC intervention after study completion.

0 / 2Eligibility criteria met